Cargando…
Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma
BACKGROUND: Several recent studies demonstrated that microRNAs are stably detectable in plasma/serum. We tested whether miR-18a, which is located in the miR-17-92 cluster and reported to be highly expressed in tissues of oesophageal squamous cell carcinoma (ESCC), served as a plasma biomarker in pat...
Autores principales: | Hirajima, S, Komatsu, S, Ichikawa, D, Takeshita, H, Konishi, H, Shiozaki, A, Morimura, R, Tsujiura, M, Nagata, H, Kawaguchi, T, Arita, T, Kubota, T, Fujiwara, H, Okamoto, K, Otsuji, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658511/ https://www.ncbi.nlm.nih.gov/pubmed/23579215 http://dx.doi.org/10.1038/bjc.2013.148 |
Ejemplares similares
-
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011) -
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
por: Kawaguchi, T, et al.
Publicado: (2013) -
Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
por: Takeshita, H, et al.
Publicado: (2010) -
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
por: Morimura, R, et al.
Publicado: (2011) -
Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)